Genome-wide analysis of primary microRNA expression using H3K36me3 ChIP-seq data

Area of Science:

• Molecular Biology
• Genetics
• Epigenetics
• Cardiovascular Research

Background:

• MicroRNAs (miRNAs) are crucial regulators of cell homeostasis and potential disease biomarkers.
• Investigating miRNA synthesis and transcriptional regulation presents significant challenges.
• Altered miRNA expression is linked to various disease outcomes.

Purpose of the Study:

• To validate H3K36me3 histone modification as a method for quantifying miRNA transcription levels.
• To gain new insights into cell-type-specific miRNA regulation in different tissues and disease models.
• To investigate miRNA transcriptional changes in cardiomyocytes with a GATA4 mutation associated with cardiac defects.

Main Methods:

• Utilized data from the ENCODE Consortium to validate H3K36me3 for miRNA transcription quantification.
• Applied the validated method to analyze cell-type-specific miRNA regulation in various models.
• Examined miRNA transcription and chromatin accessibility (super-enhancers, chromatin interaction profiles) in patient-derived cardiomyocytes with a GATA4 mutation.

Main Results:

• Validated H3K36me3 as a reliable marker for quantifying miRNA transcription.
• Identified altered miRNA gene transcription in cardiomyocytes with the GATA4 G296S mutation.
• Observed novel super-enhancers and changes in chromatin regulation coinciding with altered miRNA transcription, including elevated let-7a and miR-100.

Conclusions:

• Developed and validated a novel methodology for quantifying miRNA gene expression using histone marker data.
• Provided new insights into cell-type-specific miRNA transcriptional regulation in the context of cardiac disease.
• The findings pave the way for further functional studies on miRNA dysregulation in disease pathology, particularly concerning the Hippo signaling pathway.